Open AccessVariants in the SCN 5A Promoter Associated With Various Arrhythmia Phenotypes
Author(s) -
Yagihara Nobue,
Watanabe Hiroshi,
Barnett Phil,
DuboscqBidot Laetitia,
Thomas Atack C.,
Yang Ping,
Ohno Seiko,
Hasegawa Kanae,
Kuwano Ryozo,
Chatel Stéphanie,
Redon Richard,
Schott JeanJacques,
Probst Vincent,
Koopmann Tamara T.,
Bezzina Connie R.,
Wilde Arthur A. M.,
Nakano Yukiko,
Aiba Takeshi,
Miyamoto Yoshihiro,
Kamakura Shiro,
Darbar Dawood,
Donahue Brian S.,
Shigemizu Daichi,
Tanaka Toshihiro,
Tsunoda Tatsuhiko,
Suda Masayoshi,
Sato Akinori,
Minamino Tohru,
Endo Naoto,
Shimizu Wataru,
Horie Minoru,
Roden Dan M.,
Makita Naomasa
Publication year - 2016
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.003644
Subject(s) - brugada syndrome , medicine , sick sinus syndrome , atrial fibrillation , phenotype , genetics , cardiac arrhythmia , gene , cardiology , biology
Background Mutations in the coding sequence of SCN 5A , which encodes the cardiac Na + channel α subunit, have been associated with inherited susceptibility to various arrhythmias. Variable expression of SCN 5A is a possible mechanism responsible for this pleiotropic effect; however, it is unknown whether variants in the promoter and regulatory regions of SCN 5A also modulate the risk of arrhythmias. Methods and Results We resequenced the core promoter region of SCN 5A and the regulatory regions of SCN 5A transcription in 1298 patients with arrhythmia phenotypes (atrial fibrillation, n=444; sinus node dysfunction, n=49; conduction disease, n=133; Brugada syndrome, n=583; and idiopathic ventricular fibrillation, n=89). We identified 26 novel rare variants in the SCN 5A promoter in 29 patients affected by various arrhythmias (atrial fibrillation, n=6; sinus node dysfunction, n=1; conduction disease, n=3; Brugada syndrome, n=14; idiopathic ventricular fibrillation, n=5). The frequency of rare variants was higher in patients with arrhythmias than in controls. In the alignment with chromatin immunoprecipitation sequencing data, the majority of variants were located at regions bound by transcription factors. Using a luciferase reporter assay, 6 variants (Brugada syndrome, n=3; idiopathic ventricular fibrillation, n=2; conduction disease, n=1) were functionally characterized, and each displayed decreased promoter activity compared with the wild‐type sequences. We also identified rare variants in the regulatory region that were associated with atrial fibrillation, and the variant decreased promoter activity. Conclusions Variants in the core promoter region and the transcription regulatory region of SCN 5A were identified in multiple arrhythmia phenotypes, consistent with the idea that altered SCN 5A transcription levels modulate susceptibility to arrhythmias.